Kura Oncology logo

Kura Oncology Share Price Today

(NASDAQ: KURA)

Kura Oncology share price is $7.37 & ₹640.96 as on 6 Mar 2025, 2.30 'hrs' IST

$7.37

0.04

(0.55%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Kura Oncology share price in Dollar and Rupees. Guide to invest in Kura Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kura Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Kura Oncology share price movements

  • Today's Low: $7.31
    Today's High: $7.55

    Day's Volatility :3.18%

  • 52 Weeks Low: $6.98
    52 Weeks High: $24.17

    52 Weeks Volatility :71.12%

Kura Oncology (KURA) Returns

PeriodKura Oncology IncSector (Health Care)Index (Russel 2000)
3 Months
-31.56%
2.1%
0.0%
6 Months
-62.75%
-4.1%
0.0%
1 Year
-67.71%
2.2%
0.0%
3 Years
-54.75%
11.8%
-11.6%

Kura Oncology (KURA) Key Statistics

in dollars & INR

Previous Close
$7.33
Open
$7.41
Today's High
$7.55
Today's Low
$7.31
Market Capitalization
$563.8M
Today's Volume
$643.2K
52 Week High
$24.17
52 Week Low
$6.98
Revenue TTM
$53.9M
EBITDA
$-192.3M
Earnings Per Share (EPS)
$-2.02
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.38%

How to invest in Kura Oncology Stock (KURA) from India?

It is very easy for Indian residents to invest directly in Kura Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kura Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kura Oncology or KURA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kura Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kura Oncology shares which would translate to 0.118 fractional shares of Kura Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kura Oncology, in just a few clicks!

Returns in Kura Oncology (KURA) for Indian investors in Rupees

The Kura Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kura Oncology investment value today

Current value as on today

₹37,430

Returns

₹62,570

(-62.57%)

Returns from Kura Oncology Stock

₹67,533 (-67.53%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Kura Oncology (KURA)

-77%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Kura Oncology Stock from India on INDmoney has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Kura Oncology

  • BlackRock Inc

    10.20%

  • Armistice Capital, LLC

    7.46%

  • Suvretta Capital Management, LLC

    6.53%

  • Vanguard Group Inc

    6.20%

  • RA Capital Management, LLC

    5.72%

  • EcoR1 Capital, LLC

    4.57%

Analyst Recommendation on Kura Oncology

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Kura Oncology(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
18
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Kura Oncology Stock (KURA)

What analysts predicted

Upside of 275.74%

Target:

$27.69

Current:

$7.37

Insights on Kura Oncology Stock (Ticker Symbol: KURA)

  • Price Movement

    In the last 6 months, KURA stock has moved down by -62.8%
  • KURA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 127.5%
  • KURA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 100.2%
  • Price to Sales

    ForKURA every $1 of sales, investors are willing to pay $11.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Kura Oncology Technicals Summary

Sell

Neutral

Buy

Kura Oncology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Kura Oncology (KURA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kura Oncology Inc logo
-17.55%
-62.75%
-67.71%
-54.75%
-28.9%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kura Oncology Inc logo
NA
NA
0.0
-2.12
-0.42
-0.29
NA
5.45
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kura Oncology Inc logo
Buy
$563.8M
-28.9%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Kura Oncology

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, an orally bioavailable small molecule inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; and strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies. The company was founded in 2014 and is headquartered in San Diego, California.
Organization
Kura Oncology
Employees
0
CEO
Dr. Troy Edward Wilson J.D., Ph.D.
Industry
Health Technology

Management People of Kura Oncology

NameTitle
Dr. Troy Edward Wilson J.D., Ph.D.
Chairman, CEO & President
Ms. Kathleen Ford
Chief Operating Officer
Ms. Teresa Brophy Bair Esq., J.D.
Chief Legal Officer & Corporate Secretary
Mr. Thomas Doyle
Senior Vice President of Finance & Accounting
Dr. Francis J. Burrows Ph.D.
Chief Scientific Officer
Dr. Roger Bakale Ph.D.
Senior Vice President of Manufacturing & Supply Chain
Ms. Maureen Clancy M.B.A.
VP and Global Head of Program Leadership & Project Management
Dr. Mollie Leoni M.D.
Chief Medical Officer
Mr. Brian T. Powl M.B.A., M.S.
Chief Commercial Officer

Important FAQs about investing in KURA Stock from India :

What is Kura Oncology share price today?

Kura Oncology share price today stands at $7.37, Open: $7.41 ; Previous Close: $7.33 ; High: $7.55 ; Low: $7.31 ; 52 Week High: $24.17 ; 52 Week Low: $6.98.

The stock opens at $7.41, after a previous close of $7.33. The stock reached a daily high of $7.55 and a low of $7.31, with a 52-week high of $24.17 and a 52-week low of $6.98.

Can Indians buy Kura Oncology shares?

Yes, Indians can invest in the Kura Oncology (KURA) from India.

With INDmoney, you can buy Kura Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kura Oncology at zero transaction cost.

How can I buy Kura Oncology shares from India?

It is very easy to buy Kura Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kura Oncology (KURA) be purchased?

Yes, you can buy fractional shares of Kura Oncology with INDmoney app.

What are the documents required to start investing in Kura Oncology stocks?

To start investing in Kura Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kura Oncology Stock (KURA)?

Today’s highest price of Kura Oncology (KURA) is $7.55.

Today’s lowest price of Kura Oncology (KURA) is $7.31.

What is today's market capitalisation of Kura Oncology?

Today's market capitalisation of Kura Oncology KURA is 563.8M

What is the 52 Week High and Low Range of Kura Oncology Stock (KURA)?

  • 52 Week High

    $24.17

  • 52 Week Low

    $6.98

What are the historical returns of Kura Oncology (KURA)?

  • 1 Month Returns

    -17.55%

  • 3 Months Returns

    -62.75%

  • 1 Year Returns

    -67.71%

  • 5 Years Returns

    -28.9%

Who is the Chief Executive Officer (CEO) of Kura Oncology ?

Dr. Troy Edward Wilson J.D., Ph.D. is the current Chief Executive Officer (CEO) of Kura Oncology.